Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Haihai Liang; Tong Yu; Yue Han; Hua Jiang; Chengyu Wang; Tianyi You; Xiaoguang Zhao; Huitong Shan; Rui Yang; Lida Yang; Hongli Shan; Yunyan Gu

doi:10.1186/s12943-021-01344-4

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Mol Cancer. 2021 Apr 9;20(1):64. doi: 10.1186/s12943-021-01344-4.

Authors

Haihai Liang^#^{1

2}, Tong Yu^#^{1

2}, Yue Han^#³, Hua Jiang^{1

2}, Chengyu Wang³, Tianyi You³, Xiaoguang Zhao^{1

2}, Huitong Shan^{1

2}, Rui Yang^{1

2}, Lida Yang^{1

2}, Hongli Shan^{1

2}, Yunyan Gu^{4

5}

Affiliations

¹ Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
² Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, 150081, China.
³ Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, China.
⁴ Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150086, China. [email protected].
⁵ Training Center for Students Innovation and Entrepreneurship Education, Harbin Medical University, Harbin, 150086, China. [email protected].

^# Contributed equally.

No abstract available

Publication types

Published Erratum